Sellas Life Sciences
SLS
13.66
-1.20
-8.08%
Sellas Life Sciences
US · SLS
#2687 by market cap
Listed 1970
13.66
-1.20
-8.08%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:58
About Sellas Life Sciences
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
- Founded
- 2006
- CEO
- Dr. Angelos M. Stergiou, M.D.,Sc.D.
- Employees
- 13
- Headquarters
- New York, New York, United States of America
- Fiscal year end
- 12-31
- Website
- sellaslifesciences.com
Company profile
- Exchange
- US
- Symbol
- SLS
- Market-cap rank
- #2687
- Listing date
- 1970-01-01
- Market cap
- 2.78B
- Float cap
- 2.77B
- Shares out
- 203.86M
- Float shares
- 203.06M
Sectors & themes
Quote time 2026-11-20 19:58:45 · For reference only, not investment advice and not tailored to your situation.
Sellas Life Sciences discussion 0 comments